Since CD4 T cells take also part in the activation of CD8 T cells (74) and their long-lasting maintenance in vivo (75, 76), it stands to reason that B cells could play a pivotal role in orchestrating intratumor antitumor immunity in HNSCC. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.